Explore the words cloud of the PIGYVAX project. It provides you a very rough idea of what is the project "PIGYVAX" about.
The following table provides information about the project.
Coordinator |
INSTITUT PASTEUR
Organization address contact info |
Coordinator Country | France [FR] |
Project website | http://www.pigsdontcry.com and https |
Total cost | 185˙076 € |
EC max contribution | 185˙076 € (100%) |
Programme |
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility) |
Code Call | H2020-MSCA-IF-2015 |
Funding Scheme | MSCA-IF-EF-ST |
Starting year | 2016 |
Duration (year-month-day) | from 2016-06-13 to 2018-06-12 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | INSTITUT PASTEUR | FR (PARIS CEDEX 15) | coordinator | 185˙076.00 |
PIGYVAX aims to create pig vaccine candidates against PEDV, a pathogen of swine causing significant challenges to the swine industry globally. This project will utilize yeast-based vaccine carrying nanoparticles of measles ribonucleoprotein (RNP) fused with PEDV spike protein (S1). The multimerization of monomeric S1 antigen through RNP will increase immunogenicity due to better recognition of antigen presenting cells. As the yeast delivery system has strong auto-adjuvant properties, the vaccine does not require complementation with accessory adjuvant, which reduces the cost of vaccine production. Moreover, P. pastoris yeast, commonly present on fruits, is a certified safe microorganism for animal feeds rendering it a most practical and convenient way to deliver vaccines to large-scale farms. Therefore, we aim to use this vaccine platform to express S1 antigen of PEDV and deliver it orally to stimulate a protective immune response against PEDV in sows, which will be passively transferred to fully protect piglets from succumbing to the disease. In this project, Dr. Phanramphoei Frantz will utilize her knowledge on pathogenesis of PEDV and the yeast-RNP platform while gaining expertise on vaccine study and development from the host institute. This will initiate a successful collaboration project between Institut Pasteur and BIOTEC (Thailand) to where the experienced researcher will return after the project.
year | authors and title | journal | last update |
---|---|---|---|
2018 |
Phanramphoei N. Frantz, Samaporn Teeravechyan, Frédéric Tangy Measles-derived vaccines to prevent emerging viral diseases published pages: , ISSN: 1286-4579, DOI: 10.1016/j.micinf.2018.01.005 |
Microbes and Infection | 2019-06-13 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PIGYVAX" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PIGYVAX" are provided by the European Opendata Portal: CORDIS opendata.